(Q23922265)

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

Oxidative desulfuration of chlorpyrifos, chlorpyrifos-methyl, and leptophos by rat brain and liver.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Identification of the cytochrome P450 isoenzymes involved in the metabolism of diazinon in the rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Physiologically based modeling of nonsteady state dermal absorption of halogenated methanes from an aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Diazinon metabolism in the dog

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Malathion percutaneous absorption after repeated administration to man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Chlorpyrifos: Pharmacokinetics in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Acute effects of the organophosphate paraoxon on schedule-controlled behavior and esterase activity in rats: dose-response relationships.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Differences in the mode of lethality produced through intravenous and oral administration of organophosphorus insecticides in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Percutaneous absorption of diazinon in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

The tissue distribution of diazinon and the inhibition of blood cholinesterase activities in rats and mice receiving a single intraperitoneal dose of diazinon

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Structural bases for the specificity of cholinesterase catalysis and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Kinetic parameters of desulfuration and dearylation of parathion and chlorpyrifos by rat liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Characterization of the in vitro kinetic interaction of chlorpyrifos-oxon with rat salivary cholinesterase: a potential biomonitoring matrix

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

The importance of drug-transporting P-glycoproteins in toxicology

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Exposure to the organophosphate diazinon: data from a human volunteer study with oral and dermal doses

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Monte Carlo analysis of the human chlorpyrifos-oxonase (PON1) polymorphism using a physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Degradation of carbon-14 labeled diazinon in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Metabolism in vitro of diazinon and diazoxon in rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Rat urinary metabolites from O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl) phosphorothioate

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Movement and deposition of two organophosphorus pesticides within a residence after interior and exterior applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Validation of a whole blood method for cholinesterase monitoring

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Family approach for estimating reference concentrations/doses for series of related organic chemicals

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

In vitro rat hepatic and intestinal metabolism of the organophosphate pesticides chlorpyrifos and diazinon

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Oral and dermal absorption of chlorpyrifos: a human volunteer study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Estimation of dermal exposure to pesticides and its use in risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Physiological parameter values for physiologically based pharmacokinetic models

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021

Longitudinal investigation of dietary exposure to selected pesticides

1 reference

https://api.crossref.org/works/10.1016%2FJ.NEURO.2004.03.002

7 January 2021